Adults receiving ADHD medications and therapy frequently experience adverse events that interfere with employment and daily life.
At 12 months, rates of mortality for those diagnosed with first-episode psychosis are 24 times higher than the general population.
Sandra Steingard, writing in the journal Psychiatric Services, reviews a recent article finding that the quality of the therapeutic relationship impacts the efficacy of medication treatment.
The American Psychological Association (APA) recently published a study finding that patients assigned to drug-only treatments were more likely to refuse treatment, and more likely to drop out before treatment completion, than patients assigned to psychotherapy only.
A meta-analysis looks at the effects of researcher background on study findings for trials comparing pharmacotherapy and psychotherapy for depression.